Alpha Tau Medical Ltd. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
DRTS Nasdaq 2836 www.alphatau.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alpha Tau Medical Ltd.

Alpha Tau to Present at Jefferies Global Healthcare Conference - May 28th, 2025 6:30 am
Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update - May 19th, 2025 2:01 pm
Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors - May 12th, 2025 2:01 pm
WEX, Acelyrin, and More Stocks See Action From Activist Investors - May 9th, 2025 4:18 pm
Alpha Tau Medical And 2 Other Penny Stocks Worth Your Attention - May 8th, 2025 12:05 pm
Alpha Tau to Participate in May Investor Conferences - May 6th, 2025 6:30 am
Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical - Apr 28th, 2025 7:00 am
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals - Apr 28th, 2025 7:00 am
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma - Apr 2nd, 2025 6:30 am
Q1 Virtual Investor Summit: On-Demand Presentations Now Live - Mar 18th, 2025 1:30 pm
Sidoti Events, LLC's Virtual March Small-Cap Conference - Mar 18th, 2025 7:00 am
Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate Update - Mar 12th, 2025 2:02 pm
March 2025 Penny Stocks To Consider For Growth - Mar 3rd, 2025 10:04 am
Alpha Tau to Participate in March Investor Conferences - Feb 27th, 2025 7:00 am
Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification - Feb 24th, 2025 6:30 am
Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease - Feb 3rd, 2025 6:30 am
Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day - Jan 27th, 2025 7:00 am
US Penny Stocks To Consider In January 2025 - Jan 8th, 2025 6:09 am
Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day - Dec 18th, 2024 6:30 am
Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor - Dec 17th, 2024 7:00 am